Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | -671.09 Thousand AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 100.0% |
| 2019 | -895.98 Thousand AUD | -89598600.0% |
| 2018 | 1.00 AUD | 100.0% |
| 2017 | -1.33 Million AUD | -2109.49% |
| 2016 | -60.27 Thousand AUD | -15.77% |
| 2015 | -52.05 Thousand AUD | -22359170246246500.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | -671.09 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2024 Q2 | - AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 100.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2019 FY | -895.98 Thousand AUD | -89598600.0% |
| 2019 Q4 | -895.98 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 1.00 AUD | 100.0% |
| 2018 Q4 | 1.00 AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | -1.33 Million AUD | 0.0% |
| 2017 FY | -1.33 Million AUD | -2109.49% |
| 2016 FY | -60.27 Thousand AUD | -15.77% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | -60.27 Thousand AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | -52.05 Thousand AUD | -22359170246246500.0% |
| 2015 Q4 | -52.05 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 147.894% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 153.588% |
| Biome Australia Limited | 1.88 Million AUD | 135.534% |
| Patrys Limited | - AUD | Infinity% |
| Orthocell Limited | 1.17 Million AUD | 157.035% |
| Imugene Limited | - AUD | Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 71.555% |
| PYC Therapeutics Limited | -17.99 Million AUD | 96.271% |
| Chimeric Therapeutics Limited | - AUD | Infinity% |
| Prescient Therapeutics Limited | - AUD | Infinity% |
| Proteomics International Laboratories Limited | - AUD | Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | 720.21% |
| CSL Limited | 8.93 Billion AUD | 100.008% |
| Arovella Therapeutics Limited | - AUD | Infinity% |
| Bio-Gene Technology Limited | - AUD | Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 106.315% |
| Starpharma Holdings Limited | 2.4 Million AUD | 127.869% |
| Nanollose Limited | - AUD | Infinity% |
| Memphasys Limited | 164.76 Thousand AUD | 507.312% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | -606.539% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | Infinity% |
| Amplia Therapeutics Limited | - AUD | Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 155.491% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 23.5% |
| Race Oncology Limited | 16.4 Thousand AUD | 4191.775% |
| Nyrada Inc. | - AUD | Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 103.877% |
| Dimerix Limited | - AUD | Infinity% |
| PharmAust Limited | - AUD | Infinity% |
| Immutep Limited | 2.00 AUD | 33554700.0% |
| Clarity Pharmaceuticals Ltd | - AUD | Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | 67109300.0% |
| BTC Health Limited | - AUD | Infinity% |
| Acrux Limited | 147 Thousand AUD | 556.525% |
| Neuren Pharmaceuticals Limited | - AUD | Infinity% |
| Biotron Limited | - AUD | Infinity% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 412.54% |
| AdAlta Limited | -1.67 Million AUD | 60.043% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 32.035% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 402.489% |
| Paradigm Biopharmaceuticals Limited | - AUD | Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | 791.014% |
| Actinogen Medical Limited | 108.82 Thousand AUD | 716.648% |
| Immuron Limited | 1.58 Million AUD | 142.351% |
| Argenica Therapeutics Limited | - AUD | Infinity% |